1. Home
  2. BIOA vs QMMM Comparison

BIOA vs QMMM Comparison

Compare BIOA & QMMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIOA
  • QMMM
  • Stock Information
  • Founded
  • BIOA 2015
  • QMMM 2005
  • Country
  • BIOA United States
  • QMMM Hong Kong
  • Employees
  • BIOA N/A
  • QMMM N/A
  • Industry
  • BIOA Biotechnology: Pharmaceutical Preparations
  • QMMM
  • Sector
  • BIOA Health Care
  • QMMM
  • Exchange
  • BIOA Nasdaq
  • QMMM NYSE
  • Market Cap
  • BIOA 177.1M
  • QMMM 196.2M
  • IPO Year
  • BIOA 2024
  • QMMM 2024
  • Fundamental
  • Price
  • BIOA $5.14
  • QMMM $0.85
  • Analyst Decision
  • BIOA Hold
  • QMMM
  • Analyst Count
  • BIOA 3
  • QMMM 0
  • Target Price
  • BIOA $18.00
  • QMMM N/A
  • AVG Volume (30 Days)
  • BIOA 959.0K
  • QMMM 1.0M
  • Earning Date
  • BIOA 02-15-2025
  • QMMM 02-21-2025
  • Dividend Yield
  • BIOA N/A
  • QMMM N/A
  • EPS Growth
  • BIOA N/A
  • QMMM N/A
  • EPS
  • BIOA N/A
  • QMMM N/A
  • Revenue
  • BIOA N/A
  • QMMM $3,510,653.00
  • Revenue This Year
  • BIOA N/A
  • QMMM N/A
  • Revenue Next Year
  • BIOA N/A
  • QMMM N/A
  • P/E Ratio
  • BIOA N/A
  • QMMM N/A
  • Revenue Growth
  • BIOA N/A
  • QMMM 20.09
  • 52 Week Low
  • BIOA $3.85
  • QMMM $0.54
  • 52 Week High
  • BIOA $26.62
  • QMMM $13.00
  • Technical
  • Relative Strength Index (RSI)
  • BIOA N/A
  • QMMM N/A
  • Support Level
  • BIOA N/A
  • QMMM N/A
  • Resistance Level
  • BIOA N/A
  • QMMM N/A
  • Average True Range (ATR)
  • BIOA 0.00
  • QMMM 0.00
  • MACD
  • BIOA 0.00
  • QMMM 0.00
  • Stochastic Oscillator
  • BIOA 0.00
  • QMMM 0.00

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.

About QMMM QMMM HOLDINGS LIMITED

QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly-owned subsidiaries. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.

Share on Social Networks: